核酸四面体蓝皮书

◼tetrahedral framework nucleic acidstFNAtFNADNARNADNADNADNADNAtFNAtFNAtFNAtFNAtFNAtFNAtFNAtFNAtFNAtFNAtFNAtFNAtFNAtFNAtFNAtFNAtFNAtFNAs , as a promising nanomaterial, demonstrate significant potential in both wellness and beauty industry. But this technology also has quite a few constraints to overcome, e.g., production, safety, regulatory, etc. Shiseido CIC appreciate Trautec embrace this challenge. And sincerely congratulate Trautec on tFNAs R&D progress and Blue Paper published! As a top beauty and wellness global group, we are also looking forward to research deepening and technology advancement on tFNAs, especially efficacy and safety. In coming future, tFNAs will play a more and more important role on biomedicine and personal care, even from global wise, with joint efforts from different industries.——Shiseido China CIOAraki Hidefumi12——DNA ——◼XVII————◼tFNA is a nano high-tech material highly anticipated for use as a platform technology that can enhance efficacy not only in biomedicine and disease diagnosis but also in cosmetics, which are close to our daily lives. TrauTEC deserves credit for achieving the commercial production of tFNA, which is challenging to synthesize. We appreciate TrauTEC's efforts in pioneering an uncharted path for its first application in the cosmetics field, leading safety and efficacy tests, and sharing the process and results with the industry through the publication of the bluebook. We hope that Cosmax, the world’s leading OBM/ODM company, propagates various high-efficacy materials developed based on tFNA into cosmetics, and that we collaborate to create beauty worldwide.——COSMAX China R&I/ BCT DirectorKim YoungheuiIn 2023, we finally got big criteria of aging 12 hall marks. The change will make the game of sailing for future healthcare and beauty care in the point of aging. Last 25 years we got technology of peptides and made innovation of healthcare and especially of beauty care. And pandemic experience realized Nucleotides technology for healthcare. Trautec, here, starts next innovative technology of nucleotides, called tFNAs. This challenge will open the world for next 25 years healthcare, beauty care revolution. tFNAs has multifunction, such as drug delivery, injective tissue remodeling and also topical anti-aging property by itself. This high potential bio-material will be a key technology for coming hyper-personalized healthcare with AI and wearable monitoring system. Here Sincerely congratulate Trautec new innovation and expect continuous challenge to realize tFNA technologies in various life scene.—— Naturelab Japan R&D senior managerAtsushi TakeokaAllergantFNAstFNAstFNAs—Tony Wang◼1.1 --------------------------------101.2 --------------------------------111.3 --------------------------------121.4 --------------------------------131.4.1 DNA--------------------------------131.4.2 RNA--------------------------------141.4.3 --------------------------------161.5 --------------------------------201.6 --------

立即下载
医药生物
2024-11-18
沙利文
116页
21.92M
收藏
分享

[沙利文]:核酸四面体蓝皮书,点击即可下载。报告格式为PDF,大小21.92M,页数116页,欢迎下载。

本报告共116页,只提供前10页预览,清晰完整版报告请下载后查看,喜欢就下载吧!
立即下载
本报告共116页,只提供前10页预览,清晰完整版报告请下载后查看,喜欢就下载吧!
立即下载
水滴研报所有报告均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
相关图表
医药板块本周个股跌幅榜(扣除 ST 股)
医药生物
2024-11-18
来源:医疗保健行业:医保谈判顺利推进%2b医药行业三季报发布,关注底部改善领域和相关创新药
查看原文
医药板块整体估值溢价(扣除金融板块,2010 年至今)
医药生物
2024-11-18
来源:医疗保健行业:医保谈判顺利推进%2b医药行业三季报发布,关注底部改善领域和相关创新药
查看原文
医药板块整体估值溢价(2024 盈利预测市盈率)
医药生物
2024-11-18
来源:医疗保健行业:医保谈判顺利推进%2b医药行业三季报发布,关注底部改善领域和相关创新药
查看原文
医药子行业周涨跌幅(%)
医药生物
2024-11-18
来源:医疗保健行业:医保谈判顺利推进%2b医药行业三季报发布,关注底部改善领域和相关创新药
查看原文
医药板块相对于沪深 300 收益率
医药生物
2024-11-18
来源:医疗保健行业:医保谈判顺利推进%2b医药行业三季报发布,关注底部改善领域和相关创新药
查看原文
2022Q1-2024Q3科研服务板块单季度经营性现金流净额(亿元)
医药生物
2024-11-18
来源:医药生物行业科学服务2024Q3业绩综述:生命科学到拐点了吗?
查看原文
回顶部
报告群
公众号
小程序
在线客服
收起